Duchesnay Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Duchesnay Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10896
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Duchesnay Inc (Duchesnay) is a pharmaceutical company that offers medications for use in pregnancy. The company’s products include diclectin, an antinauseant drug used for the management of nausea and vomiting; pregvit, a supplement that allow attaining nutrient levels of folic acid, iron, and calcium; and proctofoam-HC, a mucoadhesive analgesic and anti-inflammatory foam for the relief of anorectal inflammation and swelling. It also provides ladysystem, a feminine therapy to treat urinary stress incontinence caused by pelvic floor weakening; and mictoryl indicated for symptomatic treatment of urinary incontinence or increased urinary frequency and urgency in patients with overactive bladder. The company markets pharmaceutical products and medical devices in a variety of therapeutic areas, including obstetrics and gynecology, proctology, urology, and bacterial vaginosis. Duchesnay is headquartered in Blainville, Quebec, Canada.

Duchesnay Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Duchesnay Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Duchesnay Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Duchesnay Enters Into Distribution Agreement With Tzamal Medical For Diclectin Drug 10
Licensing Agreements 11
Duchesnay Receives Rights for Osphena from Shionogi 11
Alliance Pharma Enters into Licensing Agreement with Duchesnay for Diclectin 12
Duchesnay Inc – Key Competitors 13
Duchesnay Inc – Key Employees 14
Duchesnay Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Product News 16
07/06/2018: Alliance Pharma Marketing Authorisation for Diclectin in the UK 16
06/25/2018: Actress, Mom and Singer Jana Kramer is Expecting and Again Partnering with Duchesnay USA to Spread the Word about Bonjesta (doxylamine succinate – pyridoxine hydrochloride) 17
04/02/2018: Duchesnay USA Announces Availability of Bonjesta (doxylamine succinate – pyridoxine hydrochloride) in the United States 18
Product Approvals 19
Jun 07, 2018: Alliance Pharma Announces Positive Opinion for Diclectin 19
Jul 28, 2017: Alliance Pharma announce Update on Diclectin 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Duchesnay Inc, Pharmaceuticals & Healthcare, Key Facts 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Duchesnay Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Duchesnay Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Duchesnay Enters Into Distribution Agreement With Tzamal Medical For Diclectin Drug 10
Duchesnay Receives Rights for Osphena from Shionogi 11
Alliance Pharma Enters into Licensing Agreement with Duchesnay for Diclectin 12
Duchesnay Inc, Key Competitors 13
Duchesnay Inc, Key Employees 14
Duchesnay Inc, Subsidiaries 15

List of Figures
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Duchesnay Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Innogy SE (IGY):電力:M&Aディール及び事業提携情報
    Summary Innogy SE (Innogy), a subsidiary of RWE AG, is an energy company. The company offers electricity and natural gas. It operates through its business segments such as renewables, grid and infrastructure, and retail. Innogy’s company’s grid and infrastructure segment operates electricity and gas …
  • Pioneer Natural Resources Co (PXD):企業の財務・戦略的SWOT分析
    Pioneer Natural Resources Co (PXD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • B&M European Value Retail S.A.:戦略・SWOT・企業財務分析
    B&M European Value Retail S.A. - Strategy, SWOT and Corporate Finance Report Summary B&M European Value Retail S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Hudbay Minerals Inc:企業の戦略・SWOT・財務分析
    Hudbay Minerals Inc - Strategy, SWOT and Corporate Finance Report Summary Hudbay Minerals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • DiaSorin SpA (DIA):医療機器:M&Aディール及び事業提携情報
    Summary DiaSorin S.p.A. (DiaSorin) is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry (RIA), Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techni …
  • Lyka Labs Ltd (LYKALABS)-製薬・医療分野:企業M&A・提携分析
    Summary Lyka Labs Ltd (Lyka Labs) is a developer and manufacturer of pharmaceutical formulations and active pharmaceutical ingredients. The company offers development of various formulations which include lyophilized injections, differentiated dermatological formulation, dry powder injections, and o …
  • Shell Pakistan Ltd (SHEL):企業の財務・戦略的SWOT分析
    Summary Shell Pakistan Ltd (Shell Pakistan), a subsidiary of Royal Dutch Shell plc is an oil and gas company that markets petroleum products and compressed natural gas. The company operates through three segments such as retail, lubricants and aviation. It retail segment offers a range of fuels such …
  • Stavropolenergosbyt (STSB):電力:M&Aディール及び事業提携情報
    Summary Stavropolenergosbyt, a subsidiary of Novgorodskaya energosbytovaya kompaniya is an energy and power company that supplies and distributes electricity. The company provides services such as electricity distribution, energy survey, payment information, energy audit and inspection and energy sa …
  • Alliance Oil Co Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Alliance Oil Company Ltd (AOC) is an integrated oil and gas company. It explores for, extracts, and produces crude oil and gas; refines oil; and transports and sells oil products. The company has oil and gas exploration and production fields in the Timano-Pechora, Volga-Urals and Tomsk regio …
  • EWE AG:企業の戦略的SWOT分析
    EWE AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • adidas AG (ADS):企業の財務・戦略的SWOT分析
    adidas AG (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Moldex-Metric Inc:企業の戦略的SWOT分析
    Moldex-Metric Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Zanders GmbH:企業の戦略的SWOT分析
    Zanders GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Zimnat Group:企業の戦略・SWOT・財務情報
    Zimnat Group - Strategy, SWOT and Corporate Finance Report Summary Zimnat Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Xtreme Drilling Corp (XDC):石油・ガス:M&Aディール及び事業提携情報
    Summary Xtreme Drilling Corp (Xtreme Drilling), formerly Xtreme Drilling and Coil Services Corp is an onshore drilling rig service provider for oil and gas service companies. The company's products include coiled tubing units, drilling rigs, variable frequency drive systems, integrated AC top drives …
  • Consolidated Edison Company of New York, Inc.-エネルギー分野:企業M&A・提携分析
    Summary Consolidated Edison Company of New York, Inc. (CECONY), a subsidiary of Consolidated Edison, Inc. is an energy utility that generates, transmits and distributes electricity; supplies natural gas; and generates and supplies steam. The company provides electricity and related services in New Y …
  • QUALCOMM Incorporated:企業の戦略・SWOT・財務情報
    QUALCOMM Incorporated - Strategy, SWOT and Corporate Finance Report Summary QUALCOMM Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Societe Anonyme Belge de Constructions Aeronautiques:企業の戦略・SWOT・財務分析
    Societe Anonyme Belge de Constructions Aeronautiques - Strategy, SWOT and Corporate Finance Report Summary Societe Anonyme Belge de Constructions Aeronautiques - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • Harvard Stem Cell Institute-製薬・医療分野:企業M&A・提携分析
    Summary Harvard Stem Cell Institute (HSCI), a subsidiary of Harvard University is a healthcare institute that conducts research on advance stem cell science using stem cell biology to develop new treatments and cures for disease. The institute provides research programs such as disease programs, cor …
  • Genel Energy Plc (GENL):企業の財務・戦略的SWOT分析
    Genel Energy Plc (GENL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆